Itamar Medical ⚠ Under review

About

Acquisitions · 1

Headcount over time

Offices

Q&A

What is Itamar Medical's primary focus?

Itamar Medical is a medical device and digital health company that specializes in the diagnosis and management of respiratory sleep disorders and cardiovascular conditions.

When was Itamar Medical acquired and by whom?

Itamar Medical was acquired by ZOLL Medical Corporation in December 2021 for $538,000,000.

What is Itamar Medical's core technology?

Itamar Medical's core technology is based on the Peripheral Arterial Tone (PAT) signal, which is utilized in products like WatchPAT and EndoPAT.

How many employees does Itamar Medical have?

Itamar Medical has 201-500 employees.

What was Itamar Medical's last funding round before acquisition?

Itamar Medical's last funding round was a Secondary equity round in February 2021, raising $70,000,000. Viola Fund was among the investors.

What was the amount raised in Itamar Medical's Public Offering in 2020?

In 2020, Itamar Medical had a Public Offering that raised $40,250,000.

What was a significant product launch by Itamar Medical in March 2019?

In March 2019, Itamar Medical launched WatchPAT 300, advancing home sleep apnea testing.

Did Itamar Medical acquire any companies or technologies prior to its own acquisition?

Yes, in January 2021, Itamar Medical acquired the technology and assets of Spry Health.

What was a key regulatory approval Itamar Medical received in May 2020?

In May 2020, Itamar Medical received CE Mark Approval for its WatchPAT ONE, which is the first fully disposable home sleep apnea test.

Team · 2

Giora Yaron

Founder · Founder and Chairman

Gilad Glick

President (formerly CEO)

Sectors & technology

Highlights

Tags